NCT04396899View on ClinicalTrials.gov

Safety and Efficacy of Induced Pluripotent Stem Cell-derived Engineered Human Myocardium as Biological Ventricular Assist Tissue in Terminal Heart Failure

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

February 3, 2020

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Heart Failure
Interventions
BIOLOGICAL

EHM implantation

Implantation of EHM on dysfunctional left or right ventricular myocardium in patients with HFrEF (EF \<35%).

Trial Locations (3)

23562

RECRUITING

University Medical Center Schleswig-Holstein, Lübeck

32545

NOT_YET_RECRUITING

Herz- und Diabeteszentrum Nordrhein-Westfalen, Bad Oeynhausen

37075

RECRUITING

University Medical Center Göttingen, Göttingen

All Listed Sponsors
collaborator

Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)

OTHER

collaborator

University Medical Center Freiburg

OTHER

collaborator

Repairon GmbH

UNKNOWN

lead

University Medical Center Goettingen

OTHER